sST2 and Heart Failure-Clinical Utility and Prognosis.

Dudek, Magdalena; Kaluzna-Oleksy, Marta; Migaj, Jacek; Sawczak, Filip; Krysztofiak, Helena; Lesiak, Maciej; Straburzynska-Migaj, Ewa

Dudek, Magdalena; Kaluzna-Oleksy, Marta; Migaj, Jacek; Sawczak, Filip; Krysztofiak, Helena; Lesiak, Maciej; Straburzynska-Migaj, Ewa.

Afiliação

Dudek M; 1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
Kaluzna-Oleksy M; Heliodor Swiecicki Clinical Hospital in Poznan, 60-355 Poznan, Poland.
Migaj J; 1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
Sawczak F; Heliodor Swiecicki Clinical Hospital in Poznan, 60-355 Poznan, Poland.
Krysztofiak H; 1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.
Lesiak M; Heliodor Swiecicki Clinical Hospital in Poznan, 60-355 Poznan, Poland.
Straburzynska-Migaj E; 1st Department of Cardiology, Poznan University of Medical Sciences, 61-848 Poznan, Poland.

J Clin Med ; 12(9)2023 Apr 26.

Article em En | MEDLINE | ID: mdl-37176577

Palavras-chave

HFrEF; biomarker; heart failure; sST2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google